Neurontin Fraudulent Marketing Class Action

TBS represented a national class of insurance providers alleging that in an effort to boost profits, Pfizer, Inc. and Warner-Lambert Co. sold the drug Neurontin for uses for which it was neither approved by the U.S. Food and Drug Administration nor medically effective. Pfizer Inc. agreed to pay $325 million to resolve the class’s claim that Pfizer defrauded insurers and other healthcare benefit providers by its off label marketing of Neurontin.

Case Documents

Tousley Brain Stephens is one of the best law firms in Seattle. Fast, nimble and relationship focused.
Aaron Blank - The Fearey Group Contact Us
Janissa - I would never talk to any lawyer about anything until I talk to you first. You are just simply AMAZING and not only did you go completely above and beyond to ensure my daughter's trust was safe and secure, but every time I thought I couldn't go on, you constantly assured me that everything would be all right.
Sophia Cosola Contact Us
Rodger and team worked diligently to ensure that our acquisition of Media+ went through as smoothly as possible. Rodger is a wealth of knowledge and provided the consultation and counsel that we needed in order to move our deal forward and have a successful transition.
Lauren Portman, Managing Partner - Media+ Contact Us